Schedule of Presentations:

Monday, January 26, 2009
08:30:00 Registration for Pre-Conference Events*
09:00:00 Chairperson’s Opening Remarks
09:05:00 in vivo Discovery and Validation of Biomarkers of Human Drug Response and Resistance Joerg Heyer
09:30:00 Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
09:55:00 Development of Clinically Relevant Gene Expression Profiles for Prognosis of Early Stage Breast Cancer Richard Bender
10:20:00 Networking Coffee Break
10:40:00 Circulating HER-2/neu, A Biomarker for HER-2 Positive Breast Cancer, from Discovery to Patient Management Walter P. Carney
11:00:00 Pre-Conference Short Course* Jean W Lee, John L. Allinson
11:05:00 Discovery of miRNA-Based Biomarkers for Cancer Søren Møller
11:30:00 Lunch on your own
12:30:00 Cancer Biomarker Discovery in the Context of Personalized Medicine Josip Blonder
12:55:00 Industrialized Proteomics for the Discovery and Validation of Oncology Biomarkers Daniel Chelsky
13:20:00 Metabolite Biomarkers of Prostate Cancer Aggressivity Jeffrey Shuster
13:45:00 Networking Refreshment Break
14:10:00 From Discovery to the Clinic: The Novel DNA Methylation Biomarker, Septin 9, for the Detection of Colorectal Cancer in Blood Shannon Payne
14:35:00 Multiplexed Analysis of Glycan Variation on Serum Proteins Using An Antibody Array for Biomarker Profiling Bryce P Nelson
15:00:00 Conference Registration
15:00:00 Close of Workshop
16:00:00 Welcoming Remarks from Conference Director Julia Boguslavsky
16:10:00 Chairperson’s Opening Remarks
16:15:00 Use of Biomarkers and Translational Science to Accelerate and Improve Oncology Drug Development: Opportunities and Roadblocks J Carl Barrett
16:45:00 To be Announced
17:15:00 Reception with Exhibit and Poster Viewing
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.